Schott JW - Search Results

1

Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B.

Schott JW, Huang P, Morgan M, Nelson-Brantley J, Koehler A, Renslo B, Büning H, Warnecke A, Schambach A, Staecker H. Schott JW, et al. Mol Ther. 2023 Dec 6;31(12):3502-3519. doi: 10.1016/j.ymthe.2023.10.018. Epub 2023 Oct 31. Mol Ther. 2023. PMID: 37915173 Free PMC article.

2

Viral and non-viral approaches for transient delivery of mRNA and proteins.

Schott JW, Galla M, Godinho T, Baum C, Schambach A. Schott JW, et al. Curr Gene Ther. 2011 Oct;11(5):382-98. doi: 10.2174/156652311797415872. Curr Gene Ther. 2011. PMID: 21787295 Review.

3

Improved retroviral episome transfer of transcription factors enables sustained cell fate modification.

Schott JW, Hoffmann D, Maetzig T, Müller FJ, Steinemann D, Zychlinski D, Cantz T, Baum C, Schambach A. Schott JW, et al. Gene Ther. 2014 Nov;21(11):938-49. doi: 10.1038/gt.2014.69. Epub 2014 Aug 7. Gene Ther. 2014. PMID: 25102011

4

Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors.

Schott JW, Jaeschke NM, Hoffmann D, Maetzig T, Ballmaier M, Godinho T, Cathomen T, Schambach A. Schott JW, et al. Cytometry A. 2015 May;87(5):405-18. doi: 10.1002/cyto.a.22650. Epub 2015 Feb 27. Cytometry A. 2015. PMID: 25728583 Free article.

5

Retrovirus-based vectors for transient and permanent cell modification.

Schott JW, Hoffmann D, Schambach A. Schott JW, et al. Curr Opin Pharmacol. 2015 Oct;24:135-46. doi: 10.1016/j.coph.2015.09.004. Epub 2015 Oct 1. Curr Opin Pharmacol. 2015. PMID: 26433198 Review.

6

Viral and Synthetic RNA Vector Technologies and Applications.

Schott JW, Morgan M, Galla M, Schambach A. Schott JW, et al. Mol Ther. 2016 Sep;24(9):1513-27. doi: 10.1038/mt.2016.143. Epub 2016 Jul 5. Mol Ther. 2016. PMID: 27377044 Free PMC article. Review.

7

Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells.

Hoffmann D, Schott JW, Geis FK, Lange L, Müller FJ, Lenz D, Zychlinski D, Steinemann D, Morgan M, Moritz T, Schambach A. Hoffmann D, et al. Among authors: schott jw. Gene Ther. 2017 May;24(5):298-307. doi: 10.1038/gt.2017.20. Epub 2017 Apr 20. Gene Ther. 2017. PMID: 28346436

8

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.

Geis FK, Galla M, Hoffmann D, Kuehle J, Zychlinski D, Maetzig T, Schott JW, Schwarzer A, Goffinet C, Goff SP, Schambach A. Geis FK, et al. Among authors: schott jw. Retrovirology. 2017 May 31;14(1):34. doi: 10.1186/s12977-017-0358-1. Retrovirology. 2017. PMID: 28569216 Free PMC article.

9

Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis.

Biasco L, Rothe M, Schott JW, Schambach A. Biasco L, et al. Among authors: schott jw. Hematol Oncol Clin North Am. 2017 Oct;31(5):737-752. doi: 10.1016/j.hoc.2017.06.009. Hematol Oncol Clin North Am. 2017. PMID: 28895844 Review.

10

Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.

Geis FK, Galla M, Hoffmann D, Kuehle J, Zychlinski D, Maetzig T, Schott JW, Schwarzer A, Goffinet C, Goff SP, Schambach A. Geis FK, et al. Among authors: schott jw. Retrovirology. 2017 Oct 18;14(1):48. doi: 10.1186/s12977-017-0372-3. Retrovirology. 2017. PMID: 29047401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters